| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 21/03/2025 |
| olanzapine | Tablet, film coated | 7.5 mg | Current | Limited Availability | Manufacturing | 21/03/2025 |
| sulfamethoxazole~trimethoprim | Injection, concentrated | 80 mg/mL~16 mg/mL | Anticipated | Available | Manufacturing | 21/03/2025 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Anticipated | Available | Manufacturing | 21/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Resolved | Available | Manufacturing | 21/03/2025 |
| Belimumab | Injection, powder for | 120 mg | Current | Limited Availability | Manufacturing | 21/03/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Anticipated | Available | Manufacturing | 21/03/2025 |
| risperidone | Tablet, film coated | .5 mg | Anticipated | Available | Manufacturing | 21/03/2025 |
| quetiapine fumarate | Tablet, modified release | 345.39 mg | Resolved | Available | Manufacturing | 21/03/2025 |
| morphine hydrochloride trihydrate | Injection, solution | 20 mg/mL | Current | Limited Availability | Manufacturing | 21/03/2025 |
| esomeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 21/03/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 21/03/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Anticipated | Available | Manufacturing | 21/03/2025 |
| trimethoprim | Tablet, uncoated | 300 mg | Anticipated | Available | Manufacturing | 21/03/2025 |
| sodium nitroprusside | Injection, concentrated | 50 mg | Anticipated | Available | Commercial Changes / Commercial viability | 21/03/2025 |
| tamoxifen citrate | Tablet, uncoated | 30.4 mg | Current | Limited Availability | Manufacturing | 21/03/2025 |
| naproxen | Tablet, uncoated | 250 mg | Anticipated | Available | Manufacturing | 21/03/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Resolved | Available | Manufacturing | 21/03/2025 |
| dorzolamide hydrochloride | Eye Drops, solution | 22.26 mg/mL | Resolved | Available | Manufacturing | 21/03/2025 |
| dalteparin sodium | Injection, solution | 18000 anti-Xa IU | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 21/03/2025 |
| dalteparin sodium | Injection, solution | 15000 anti-Xa IU | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 21/03/2025 |
| dalteparin sodium | Injection, solution | 12500 anti-Xa IU | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 21/03/2025 |
| temazepam | Tablet, uncoated | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 21/03/2025 |
| timolol maleate~dorzolamide hydrochloride | Eye Drops, solution | 6.83 mg/mL~22.26 mg/mL | Resolved | Available | Manufacturing | 21/03/2025 |
| minocycline hydrochloride dihydrate | Tablet, film coated | 54 mg | Current | Limited Availability | Manufacturing | 21/03/2025 |
| fentanyl citrate~ropivacaine hydrochloride | Injection, solution | 3.14 microgram/mL~2 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 21/03/2025 |
| prazosin hydrochloride | Tablet, uncoated | 1.095 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 20/03/2025 |
| prazosin hydrochloride | Tablet, uncoated | 2.19 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 20/03/2025 |
| fentanyl | Drug delivery system, transdermal | 4.2 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 20/03/2025 |
| fentanyl | Drug delivery system, transdermal | 16.8 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 20/03/2025 |
| olanzapine | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| amisulpride | Tablet | 100 mg | Resolved | Available | Manufacturing | 20/03/2025 |
| losartan potassium | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| losartan potassium | Tablet, film coated | 25 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| salmeterol xinafoate~fluticasone propionate | Inhalation, powder for | 72.5 microgram/actuation~100 microgram/actuation | Resolved | Available | Unexpected increase in consumer demand | 20/03/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 20/03/2025 |
| drospirenone~ethinylestradiol | Tablet | 3 mg~.03 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 20/03/2025 |
| ethinylestradiol~drospirenone | Tablet | .02 mg~3 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 20/03/2025 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| celecoxib | Capsule, hard | 100 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Unexpected increase in consumer demand | 20/03/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 82.725 mg~10 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 41.363 mg~10 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~20.681 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| dosulepin (dothiepin) hydrochloride | Capsule, hard | 25 mg | Anticipated | Available | Manufacturing | 20/03/2025 |
| tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Unavailable | Manufacturing | 20/03/2025 |
| iopromide | Injection, solution | 498.72 mg/mL | Anticipated | Available | Manufacturing | 20/03/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.96 mg | Current | Limited Availability | Manufacturing | 20/03/2025 |
| risperidone | Tablet, film coated | .5 mg | Anticipated | Available | Manufacturing | 19/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 19/03/2025 |
| fenofibrate | Tablet, film coated | 145 mg | Current | Limited Availability | Manufacturing | 19/03/2025 |
| cisplatin | Injection, concentrated | 1 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 19/03/2025 |
| pegaspargase | Solution, powder for | 750 U/mL | Anticipated | Available | Manufacturing | 19/03/2025 |
| gemfibrozil | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 19/03/2025 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 19/03/2025 |
| primidone | Tablet, uncoated | 250 mg | Current | Limited Availability | Manufacturing | 18/03/2025 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 18/03/2025 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Current | Limited Availability | Manufacturing | 18/03/2025 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 41.583 mg~10 mg | Current | Unavailable | Manufacturing | 18/03/2025 |
| bimatoprost | Eye Drops | .3 mg/mL | Current | Unavailable | Manufacturing | 18/03/2025 |
| mupirocin | Ointment | 20 mg/g | Current | Limited Availability | Unexpected increase in consumer demand | 18/03/2025 |
| flecainide acetate | Tablet | 50 mg | Discontinued | Unavailable | Manufacturing | 18/03/2025 |
| amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide | Tablet, film coated | 6.95 mg~40 mg~12.5 mg | Resolved | Available | Manufacturing | 18/03/2025 |
| mycophenolate sodium | Tablet, enteric coated | 384.7 mg | Resolved | Available | Manufacturing | 18/03/2025 |
| Bevacizumab | Injection, concentrated | 25 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 18/03/2025 |
| cisatracurium besilate | Injection, solution | 2.68 mg/mL | Resolved | Available | Manufacturing | 18/03/2025 |
| norethisterone~ethinylestradiol | Tablet, uncoated | 500 microgram~36 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 18/03/2025 |
| famotidine | Tablet, film coated | 40 mg | Resolved | Available | Manufacturing | 18/03/2025 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/03/2025 |
| tacrolimus monohydrate | Capsule, hard | 1.022 mg | Resolved | Available | Unexpected increase in consumer demand | 17/03/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/03/2025 |
| trandolapril | Capsule, hard | 4 mg | Current | Unavailable | Manufacturing | 17/03/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/03/2025 |
| midazolam | Injection, solution | 15 mg | Current | Limited Availability | Manufacturing | 17/03/2025 |
| carboplatin | Injection, solution | 450 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/03/2025 |
| tacrolimus monohydrate | Capsule | .767 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 17/03/2025 |
| Influenza virus haemagglutinin | Injection, suspension | 15 microgram | Discontinued | Unavailable | Commercial Changes / Commercial viability | 17/03/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 17/03/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Unavailable | Manufacturing | 17/03/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 17/03/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 17/03/2025 |
| permethrin | Cream | 50 mg/g | Current | Limited Availability | Commercial Changes / Commercial viability | 17/03/2025 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| cisatracurium besilate | Injection, solution | 6.7 mg/mL | Resolved | Available | Manufacturing | 17/03/2025 |
| cabergoline | Tablet, uncoated | 2 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| ethinylestradiol~norethisterone | Tablet, uncoated | 36 microgram~1 mg | Current | Limited Availability | Manufacturing | 17/03/2025 |
2025年3月23日